Noninfective disorders of pinna

H8_PINNADIS

auditory system disease: Pathological processes of the ear, the hearing, and the equilibrium system of the body.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H61.1 Hospital discharge: ICD-9 — 3803 Cause of death: ICD-10 — H61.1 Cause of death: ICD-9 — 3803 2 out of 7 registries used, show all original rules.	83
4. Check minimum number of events None	83
5. Include endpoints None	83
6. Filter based on genotype QC (FinnGen only)	78

Control definitions (FinnGen only)

Control exclude: H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H61
Name in latin: Morbositates non infectiosae auriculae

NAME	H8_PINNADIS
CONTROL_EXCLUDE	H8_EXTERNAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H611
HD_ICD_9	3803
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H611
COD_ICD_9	3803
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Noninfective disorders of pinna based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	684	319	359
Only index persons	610	287	323
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	32.55	34.65	30.36
Only index persons	32.98	37.05	29.37

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	78	46	32
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	52.66	47.98	59.38

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
83: Matched controls
830

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H61.1

ICD-10 Finland

Noninfective disorders of pinna

+∞

94.9

H29

ICPC

Ear symptom/complaint other

5.3

7.9

3803B

ICD-9 Finland

Disorders of external ear, Non-infectious disorders of pinna[DEFORMATIO AURICULARIS AQCUISITA]

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

4.63

8.31

1.8

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

3.03

3.88

1.2

1.4

173.33

446.32

titre

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3.14

3.76

1.9

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3.06

3.46

1.9

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

145

2.28

2.86

2.4

1.3

1.89

2.29

g/l

0.87

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.38

2.52

2.0

1.9

—

(3034770) Mitochondria Ab [Titer] in Serum

5.29

2.44

1.2

1.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

162

1.99

2.09

1.3

1.2

7.49

0.93

u/ml

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.84

1.93

2.1

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

328

1.81

1.88

5.0

5.7

1.81

1.84

e9/l

0.12

299

(3006315) Basophils [#/volume] in Blood

313

1.78

5.1

5.8

0.04

e9/l

0.04

280

(3001604) Monocytes [#/volume] in Blood

313

1.78

5.1

5.7

0.54

0.56

e9/l

0.25

279

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

4.02

1.74

1.0

1.3

—

(3013115) Eosinophils [#/volume] in Blood

324

1.76

1.74

5.0

5.9

0.18

e9/l

0.00

294

(3013650) Neutrophils [#/volume] in Blood by Automated count

367

1.73

1.62

7.3

10.4

4.47

3.90

e9/l

0.63

333

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2.84

1.62

1.0

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

3.00

1.53

1.2

5.63

5.79

u/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

470

1.68

1.34

3.2

3.0

—

(3021589) Normoblasts [#/volume] in Blood

307

1.58

1.23

8.9

8.6

0.00

0.01

e9/l

0.50

254

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

158

1.63

1.09

1.7

3.6

633.86

956.77

ng/l

0.66

132

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

515

1.60

1.07

3.8

4.0

14.49

14.84

pmol/l

0.55

475

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2.35

1.05

1.6

1.0

401.60

500.32

mg/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

288

1.51

1.02

5.8

6.0

—

(3023368) Bacteria identified in Blood by Culture

161

1.59

1.01

5.0

4.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

479

1.52

0.96

3.9

4.0

15.14

11.10

mm/h

0.74

451

(3004588) Protein electrophoresis panel - Serum or Plasma

2.31

0.95

3.3

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.65

0.86

2.9

2.4

3.50

1.95

e6/l

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.82

0.84

2.2

2.5

362.00

365.02

nmol/l

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.94

0.83

4.7

7.0

23.78

24.19

mmol/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

242

1.45

0.82

4.2

2.6

—

(40768443) Skin Pathology biopsy report

1.88

0.81

1.3

1.2

—

(40768793) Breast Pathology biopsy report

0.00

0.80

0.0

1.3

—

(40768804) Tissue Pathology biopsy report

252

1.44

0.80

2.5

2.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

689

1.68

0.78

15.5

12.8

27.65

20.12

mg/l

0.75

542

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.75

0.78

1.4

2.0

—

(3002256) Pathology report gross observation

1.68

0.76

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.63

0.74

1.8

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.82

0.73

1.3

1.0

—

(3018095) Leukocytes [#/volume] in Urine

256

1.41

0.73

3.1

15.42

52.91

e6/l

1.12

184

(3000494) Fungus identified in Specimen by Culture

1.68

0.72

1.9

1.4

—

(4200892) Spirometry reversibility

1.77

0.72

1.0

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.98

0.72

3.0

1.8

24.80

41.08

nmol/l

—

(3022217) INR in Platelet poor plasma by Coagulation assay

278

1.38

0.67

17.9

10.9

1.18

1.17

inr

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.61

0.0

2.4

—

3.54

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.56

0.60

2.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

152

1.42

0.59

2.2

3.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

190

0.68

0.58

2.1

2.9

—

(40761535) Cells panel - Urine sediment

1.62

0.55

5.2

3.7

—

(3044889) 12 lead EKG panel

443

1.32

0.55

4.0

3.6

—

(40758558) Short blood count panel - Blood

173

1.37

0.54

8.0

6.4

—

(3026008) Bacteria identified in Urine by Culture

197

0.71

0.52

2.6

2.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

250

0.74

0.51

4.1

3.7

23.34

32.39

ng/l

0.37

165

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

106

1.39

0.42

2.8

2.3

0.78

1.20

e6/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.37

0.42

3.1

3.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.41

0.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

2.2

—

0.32

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.50

0.41

1.0

1.1

—

(3042936) Bacteria identified in Isolate by Culture

1.43

0.41

2.0

1.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

247

1.27

0.41

2.5

1.8

101.43

98.71

pmol/l

0.13

129

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

640

0.77

0.41

4.5

3.6

1.29

1.33

mmol/l

0.26

591

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.43

0.40

1.9

1.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.40

0.0

3.4

—

54.19

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.2

—

61.07

—

(3019309) Folate [Moles/volume] in Red Blood Cells

117

1.34

0.38

1.7

974.63

1258.23

nmol/l

—

(3002582) Erythrocytes [#/volume] in Urine

220

1.26

0.38

3.2

2.6

16.18

29.92

e6/l

0.56

171

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

136

1.31

0.37

1.8

1.7

1.23

1.32

mg/l

0.08

113

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.50

0.37

1.0

1.3

—

(36304419) Bacteria [Presence] in Urine

202

1.26

0.37

2.9

2.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.66

0.35

1.2

1.3

—

(3000991) Gas panel - Venous blood

1.33

0.34

4.3

8.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.33

0.34

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

257

0.80

0.32

2.5

3.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

139

1.28

0.32

2.4

2.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

183

0.78

0.31

7.8

3.3

5.13

11.11

mg/mmol

—

104

(46235355) HIV 1 and 2 tests - Meaningful Use set

159

1.25

0.30

2.1

1.9

—

(40761536) Microorganisms panel - Urine sediment

1.34

0.29

2.5

2.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.34

0.29

5.3

8.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

123

1.27

0.28

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

640

1.24

0.27

15.9

12.1

84.46

85.07

ml/min/173m2

0.07

517

(1761868) Lipid panel - Serum or Plasma

250

0.84

0.24

2.9

2.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

643

1.22

0.23

4.8

4.2

6.00

5.85

mmol/l

0.26

599

(3003694) ABO and Rh group [Type] in Blood

197

0.83

0.23

1.4

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.5

—

3.20

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

238.70

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

2.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.21

0.0

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.21

0.0

2.1

—

97.00

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.21

0.0

3.1

—

7.19

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

5.2

—

137.67

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.21

0.0

3.1

—

1.62

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

2.3

—

6.24

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.21

0.0

5.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.21

0.0

1.4

—

(3025941) Bacteria identified in Stool by Culture

1.27

0.21

1.0

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.27

0.21

1.3

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.20

0.0

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.20

0.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.22

0.20

2.0

1.5

—

(3019150) Specific gravity of Urine by Refractometry

138

1.20

0.19

2.3

3.5

—

1.02

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

284

1.15

0.19

8.9

6.2

1.22

mmol/l

0.14

243

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.24

0.18

2.5

1.8

—

(4035726) Immunohistochemistry procedure

1.14

0.18

1.7

1.3

—

(3000492) Spirometry study

1.14

0.18

1.1

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.16

0.17

2.4

1.7

—

(3022145) Colonoscopy Study observation

1.19

0.16

1.0

1.5

—

(40768797) Stomach Pathology biopsy report

1.12

0.15

1.3

1.2

—

(40761511) CBC panel - Blood by Automated count

712

1.21

0.15

13.5

11.9

—

(3030467) Casts [#/volume] in Urine by Automated count

200

1.14

0.14

3.1

2.5

0.52

0.32

e6/l

0.25

153

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

142

1.16

0.14

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

203

1.11

0.11

2.5

2.3

—

(3035350) Ketones [Presence] in Urine by Test strip

333

1.09

0.09

2.4

3.3

0.00

estimate

—

(3021601) Nitrite [Presence] in Urine by Test strip

335

1.08

0.08

2.9

4.4

0.00

estimate

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

663

0.91

0.07

4.9

4.1

4.45

4.67

mmol/l

1.05

618

(3037467) Urinalysis macro (dipstick) panel - Urine

466

1.07

0.07

4.5

4.1

—

(3013512) EKG study

159

1.09

0.05

3.6

3.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

318

1.06

0.05

2.2

2.4

—

(3009261) Glucose [Presence] in Urine by Test strip

339

1.06

0.04

2.4

3.3

0.00

estimate

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

660

0.93

0.04

4.8

4.0

1.40

1.46

mmol/l

0.54

613

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

102

1.09

0.03

2.6

2.0

—

(3029937) Albumin [Presence] in Urine by Test strip

184

1.04

0.00

2.9

3.6

0.00

estimate

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

148

1.02

0.00

1.4

1.6

455.10

438.28

pmol/l

—

129

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

127

1.03

0.00

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

673

0.98

0.00

4.9

4.5

2.61

2.77

mmol/l

0.82

627

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

3.3

—

4.04

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

0.93

0.00

5.3

7.0

103.71

103.00

mmol/l

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.0

1.8

—

66.00

—

(3000012) Reticulocyte production index

0.00

0.0

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

3.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

1.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

3.3

—

106.63

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(3015183) Erythrocyte sedimentation rate

0.00

-0.00

0.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

-0.00

0.0

3.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

75.20

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

-0.00

0.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

11.6

—

825.60

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3045716) Anion gap in Serum or Plasma

0.00

-0.00

0.0

2.2

—

6.58

—

(3003396) Base excess in Arterial blood by calculation

1.00

-0.00

5.3

7.1

0.22

0.54

mmol/l

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

-0.00

0.0

2.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

-0.00

0.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

239.29

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

-0.00

0.0

2.9

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

2.1

—

10.76

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

-0.00

0.0

2.0

—

66.98

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.00

-0.00

1.7

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

2.0

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(3051651) Icteric interference index of Serum or Plasma

0.00

-0.00

0.0

3.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.1

—

(3044941) Cell count panel - Synovial fluid

0.00

-0.00

0.0

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.6

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

15.4

—

1576.80

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(36660697) Celiac disease serology panel - Serum

0.95

-0.00

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

-0.00

0.0

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

3.0

—

(3012544) pH of Venous blood

1.00

-0.00

2.8

2.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_PINNADIS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H8_PINNADIS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: H8_PINNADIS – Noninfective disorders of pinna

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Noninfective disorders of pinna

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints